Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Dec;74(12):5697–5701. doi: 10.1073/pnas.74.12.5697

Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

J P Green, C L Johnson, H Weinstein, S Maayani
PMCID: PMC431860  PMID: 23536

Abstract

D-Lysergic acid diethylamide and D-2-bromolysergic acid diethylamide are competitive antagonists of the histamine activation of adenylate cyclase [ATP pyrophosphate-lyase (cyclizing); E.C. 4.6.1.1] in broken cell preparations of the hippocampus and cortex of guinea pig brain. The adenylate cyclase is linked to the histamine H2-receptor. Both D-lysergic acid diethylamide and D-2-bromolysergic acid diethylamide show topological congruency with potent H2-antagonists. D-2-Bromolysergic acid diethylamide is 10 times more potent as an H2-antagonist than cimetidine, which has been the most potent H2-antagonist reported, and D-lysergic acid diethylamide is about equipotent to cimetidine. Blockade of H2-receptors could contribute to the behavioral effects of D-2-bromolysergic acid diethylamide and D-lysergic acid diethylamide.

Full text

PDF
5697

Images in this article

5700Image
on p.5700
5700Image
on p.5700
5700Image
on p.5700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABRAMSON H. A., SKLAROFSKY B., BARON M. O., FREMONT-SMITH N. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). AMA Arch Neurol Psychiatry. 1958 Feb;79(2):201–207. [PubMed] [Google Scholar]
  2. ADEY W. R., BELL F. R., DENNIS B. J. Effects of LSD-25, psiolocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat. Neurology. 1962 Sep;12:591–602. doi: 10.1212/wnl.12.9.591. [DOI] [PubMed] [Google Scholar]
  3. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. AXELROD J., BRADY R. O., WITKOP B., EVARTS E. V. The distribution and metabolism of lysergic acid diethylamide. Ann N Y Acad Sci. 1957 Mar 14;66(3):435–444. doi: 10.1111/j.1749-6632.1957.tb40739.x. [DOI] [PubMed] [Google Scholar]
  5. Aghajanian G. K., Foote W. E., Sheard M. H. Action of psychotogenic drugs on single midbrain raphe neurons. J Pharmacol Exp Ther. 1970 Feb;171(2):178–187. [PubMed] [Google Scholar]
  6. Aghajanian G. K. LSD and 2-bromo-LSD: comparison on effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala. Neuropharmacology. 1976 Sep;15(9):521–528. doi: 10.1016/0028-3908(76)90102-7. [DOI] [PubMed] [Google Scholar]
  7. BERTINO J. R., KLEE G. D., WEINTRAUB W. Cholinesterase, dlysergic acid diethylamide, and 2-bromolysergic acid diethylamide. J Clin Exp Psychopathol Q Rev Psychiatry Neurol. 1959 Jul-Sep;20:218–222. [PubMed] [Google Scholar]
  8. Barbin G., Garbarg M., Schwartz J. C., Storm-Mathisen J. Histamine synthesizing afferents to the hippocampal region. J Neurochem. 1976 Feb;26(2):259–263. doi: 10.1111/j.1471-4159.1976.tb04474.x. [DOI] [PubMed] [Google Scholar]
  9. Bennett J. P., Jr, Snyder S. H. Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors. Mol Pharmacol. 1976 May;12(3):373–389. [PubMed] [Google Scholar]
  10. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  11. Black J. W., Durant G. J., Emmett J. C., Ganellin C. R. Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist. Nature. 1974 Mar 1;248(5443):65–67. doi: 10.1038/248065a0. [DOI] [PubMed] [Google Scholar]
  12. Bunce K. T., Parsons M. E. A quantitative study of metiamide, a histamine H2-antagonist, on the isolated whole rat stomach. J Physiol. 1976 Jun;258(2):453–465. doi: 10.1113/jphysiol.1976.sp011430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Butters N. The effect of LSD-25 on spatial and stimulus perseverative tendencies in rats. Psychopharmacologia. 1966;8(6):454–460. doi: 10.1007/BF00406494. [DOI] [PubMed] [Google Scholar]
  14. Corne S. J., Pickering R. W. A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacologia. 1967;11(1):65–78. doi: 10.1007/BF00401509. [DOI] [PubMed] [Google Scholar]
  15. Creese I., Burt D. R., Synder S. H. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. Life Sci. 1975 Dec 1;17(11):1715–1719. doi: 10.1016/0024-3205(75)90118-6. [DOI] [PubMed] [Google Scholar]
  16. DOEPFNER W. Biochemical observations on LSD-25 and Deseril. Experientia. 1962 Jun 15;18:256–257. doi: 10.1007/BF02148217. [DOI] [PubMed] [Google Scholar]
  17. Daly J. W. The nature of receptors regulating the formation of cyclic AMP in brain tissue. Life Sci. 1976 Jun 15;18(12):1349–1358. doi: 10.1016/0024-3205(76)90350-7. [DOI] [PubMed] [Google Scholar]
  18. Diab I. M., Freedman D. X., Roth L. J. ( 3 H)lysergic acid diethylamide: cellular autoradiographic localization in rat brain. Science. 1971 Sep 10;173(4001):1022–1024. doi: 10.1126/science.173.4001.1022. [DOI] [PubMed] [Google Scholar]
  19. Durant G. J., Ganellin C. R., Parsons M. E. Chemical differentiation of histamine H1- and H2-receptor agonists. J Med Chem. 1975 Sep;18(9):905–909. doi: 10.1021/jm00243a009. [DOI] [PubMed] [Google Scholar]
  20. Durant G. J., Parsons M. E., Black J. W. Potential histamine H2-receptor antagonists. 2. N-alpha-Guanylhistamine. J Med Chem. 1975 Aug;18(8):830–833. doi: 10.1021/jm00242a014. [DOI] [PubMed] [Google Scholar]
  21. Dyer D. C., Gant D. W. Vasoconstriction produced by hallucinogens on isolated human and sheep umbilical vasculature. J Pharmacol Exp Ther. 1973 Feb;184(2):366–375. [PubMed] [Google Scholar]
  22. Faragalla F. F. The subcellular distribution of lysergic acid diethylamide in the rat brain. Experientia. 1972 Dec 15;28(12):1426–1427. doi: 10.1007/BF01957828. [DOI] [PubMed] [Google Scholar]
  23. GINZEL K. H., MAYER-GROSS W. Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148). Nature. 1956 Jul 28;178(4526):210–210. doi: 10.1038/178210a0. [DOI] [PubMed] [Google Scholar]
  24. GREINER T., BURCH N. R., EDELBERG R. Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum. AMA Arch Neurol Psychiatry. 1958 Feb;79(2):208–210. doi: 10.1001/archneurpsyc.1958.02340020088016. [DOI] [PubMed] [Google Scholar]
  25. Garbarg M., Barbin G., Bischoff S., Pollard H., Schwartz J. C. Dual localization of histamine in an ascending neuronal pathway and in non-neuronal cells evidenced by lesions in the lateral hypothalamic area. Brain Res. 1976 Apr 23;106(2):333–348. doi: 10.1016/0006-8993(76)91029-5. [DOI] [PubMed] [Google Scholar]
  26. Haas H. L., Wolf P. Central actions of histamine: microelectrophoretic studies. Brain Res. 1977 Feb 18;122(2):269–279. doi: 10.1016/0006-8993(77)90294-3. [DOI] [PubMed] [Google Scholar]
  27. Hegstrand L. R., Kanof P. D., Greengard P. Histamine-sensitive adenylate cyclase in mammalian brain. Nature. 1976 Mar 11;260(5547):163–165. doi: 10.1038/260163a0. [DOI] [PubMed] [Google Scholar]
  28. ISBELL H., MINER E. J., LOGAN C. R. Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25). Psychopharmacologia. 1959;1:20–28. doi: 10.1007/BF00408108. [DOI] [PubMed] [Google Scholar]
  29. Johnson C. L., Mizoguchi H. The interaction of histamine and guanylnucleotides with cardiac adenylate cyclase and its relationship to cardiac contractility. J Pharmacol Exp Ther. 1977 Jan;200(1):174–186. [PubMed] [Google Scholar]
  30. Kakiuchi S., Rall T. W. The influence of chemical agents on the accumulation of adenosine 3',5'-Phosphate in slices of rabbit cerebellum. Mol Pharmacol. 1968 Jul;4(4):367–378. [PubMed] [Google Scholar]
  31. Key B. J. The effect of LSD-25 on the interaction between conditioned and non-conditioned stimuli in a simple avoidance situation. Psychopharmacologia. 1964 Nov 11;6(5):319–326. doi: 10.1007/BF00404242. [DOI] [PubMed] [Google Scholar]
  32. Köhler C. Habituation after dorsal hippocampal lesions: a test dependent phenomenon. Behav Biol. 1976 Sep;18(1):89–110. doi: 10.1016/s0091-6773(76)91780-6. [DOI] [PubMed] [Google Scholar]
  33. LIBERSON W. T., KARCZMAR A. G., SCHWARTZ E., ELLEN P. SYNAPTIC TRANSMISSION IN THE HIPPOCAMPUS AND PSYCHOPHARMACOLOGICAL AGENTS. Int J Neuropharmacol. 1963 Dec;2:291–302. doi: 10.1016/0028-3908(63)90005-4. [DOI] [PubMed] [Google Scholar]
  34. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  35. Lovell R. A., Freedman D. X. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs. Mol Pharmacol. 1976 Jul;12(4):620–630. [PubMed] [Google Scholar]
  36. MARSHALL P. B. Some chemical and physical properties associated with histamine antagonism. Br J Pharmacol Chemother. 1955 Sep;10(3):270–278. doi: 10.1111/j.1476-5381.1955.tb00870.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. MONROE R. R., HEATH R. G., MICKLE W. A., LLEWELLYN R. C. Correlation of rhinencephalic electrograms with behavior; a study on humans under the influence of LSD and mescaline. Electroencephalogr Clin Neurophysiol. 1957 Nov;9(4):623–642. doi: 10.1016/0013-4694(57)90084-6. [DOI] [PubMed] [Google Scholar]
  38. PURPURA D. P. Electrophysiological analysis of psychotogenic drug action. II. General nature of lysergic acid diethylamide (LSD) action on central synapses. AMA Arch Neurol Psychiatry. 1956 Feb;75(2):132–143. [PubMed] [Google Scholar]
  39. Parker R. B., Waud D. R. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. J Pharmacol Exp Ther. 1971 Apr;177(1):1–12. [PubMed] [Google Scholar]
  40. Parsons M. E., Blakemore R. C., Durant G. J., Ganellin C. R., Rasmussen A. C. Proceedings: 3-(4(5)-imidazolyl) propylguanidine (SK&F 91486) - a partial agonist at histamine H2-receptors. Agents Actions. 1975 Dec;5(5):464–464. doi: 10.1007/BF01972676. [DOI] [PubMed] [Google Scholar]
  41. Parsons M. E., Owen D. A., Ganellin C. R., Durant G. J. Dimaprit -(S-[3-(N,N-dimethylamino)prophyl]isothiourea) - a highly specific histamine H2 -receptor agonist. Part 1. Pharmacology. Agents Actions. 1977 Mar;7(1):31–37. doi: 10.1007/BF01964878. [DOI] [PubMed] [Google Scholar]
  42. Persson S. A. Effects of LSD and 2-bromo LSD on striatal DOPAC levels. Life Sci. 1977 Apr 1;20(7):1199–1205. doi: 10.1016/0024-3205(77)90493-3. [DOI] [PubMed] [Google Scholar]
  43. Persson S. A. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats. Eur J Pharmacol. 1977 May 1;43(1):73–83. doi: 10.1016/0014-2999(77)90162-5. [DOI] [PubMed] [Google Scholar]
  44. Rosecrans J. A., Lovell R. A., Freedman D. X. Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem Pharmacol. 1967 Oct;16(10):2011–2021. doi: 10.1016/0006-2952(67)90313-9. [DOI] [PubMed] [Google Scholar]
  45. SCHNECKLOTH R., PAGE I. H., DEL GRECO F., CORCORAN A. C. Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation. 1957 Oct;16(4):523–532. doi: 10.1161/01.cir.16.4.523. [DOI] [PubMed] [Google Scholar]
  46. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  47. Schwartz J. C. Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol. 1977;17:325–339. doi: 10.1146/annurev.pa.17.040177.001545. [DOI] [PubMed] [Google Scholar]
  48. Snyder S. H., Reivich M. Regional localization of lysergic acid diethylamide in monkey brain. Nature. 1966 Mar 12;209(5028):1093–1095. doi: 10.1038/2091093a0. [DOI] [PubMed] [Google Scholar]
  49. TRENDELENBURG U. The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J Pharmacol Exp Ther. 1960 Dec;130:450–460. [PubMed] [Google Scholar]
  50. Trulson M. E., Stark A. D., Jacobs B. L. Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol. 1977 Jul 15;44(2):113–119. doi: 10.1016/0014-2999(77)90097-8. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES